In the last trading session, 1.9 million shares of the Applied Therapeutics Inc (NASDAQ:APLT) were traded, and its beta was 1.93. Most recently the company’s share price was $0.41, and it changed around $0.0 or -0.02% from the last close, which brings the market valuation of the company to $58.03M. APLT currently trades at a discount to its 52-week high of $10.62, offering almost -2490.24% off that amount. The share price’s 52-week low was $0.29, which indicates that the current value has risen by an impressive 29.27% since then.
Applied Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 2.25. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 2 recommended APLT as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight. Applied Therapeutics Inc is expected to report earnings per share of -0.17 for the current quarter.
Applied Therapeutics Inc (NASDAQ:APLT) trade information
Instantly APLT has showed a red trend with a performance of -0.02% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.5800 on recent trading dayincreased the stock’s daily price by 29.31%. The company’s shares are currently down -52.13% year-to-date, but still down -32.01% over the last five days. On the other hand, Applied Therapeutics Inc (NASDAQ:APLT) is 2.91% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $4.5, which translates to bulls needing to increase their stock price by 90.89% from its current value. Analyst projections state that APLT is forecast to be at a low of $4 and a high of $5.
Applied Therapeutics Inc (APLT) estimates and forecasts
The year-over-year growth rate is expected to be 174.73%, up from the previous year.
Consensus estimates provided by 3 financial analysts predict the company will bring in an average of 416.67k in revenue for the current quarter. 3 analysts expect Applied Therapeutics Inc to make 416.67k in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 144k and 122k respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 189.35%. Forecasts for the next quarter put sales growth at 241.53%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 26.57%. Applied Therapeutics Inc earnings are expected to increase by 23.30% in 2025, but the outlook is positive 24.56% per year for the next five years.
APLT Dividends
Applied Therapeutics Inc’s next quarterly earnings report is expected to be released in June.
VR ADVISER, LLC, with 66.1112% or 9.54 million shares worth $44.57 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Simplify Exchange Traded Funds-Simplify Propel Opportunities ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Mar 31, 2025 . The former held 4.49 shares worth $1.84 million, making up 3.17% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held roughly 3.1 shares worth around $1.27 million, which represents about 2.19% of the total shares outstanding.
